Treatment of relapsing-remitting multiple sclerosis after 24 doses of natalizumab: evidence from an Italian spontaneous, prospective, and observational study (the TY-STOP Study)

Autor: Clerico, Marinella, Schiavetti, Irene, De Mercanti, Stefania F, Piazza, Federico, Gned, Dario, Brescia Morra, Vincenzo, Lanzillo, Roberta, Ghezzi, Angelo, Bianchi, Anna, Salemi, Giuseppe, Realmuto, Sabrina, Sola, Patrizia, Vitetta, Francesca, Cavalla, Paola, Paolicelli, Damiano, Trojano, Maria, Sormani, Maria Pia, Durelli, Luca, Ferraro, Diana

Publikováno v: JAMA neurology. 71(8)

Importance The evaluation of therapeutic choices is needed after 24 doses of natalizumab in patients with multiple sclerosis (MS). Objective To evaluate the effect of therapeutic choices on the mean annualized relapse rate and on magnetic resonance i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e388d66850c6e74b468d87b5f443891
https://pubmed.ncbi.nlm.nih.gov/24977406

Long-Term Effects of Alemtuzumab on CD4+ Lymphocytes in Multiple Sclerosis Patients: A 72-Month Follow-Up.

Autor: Rolla S; Department of Clinical and Biological Sciences, University of Torino, Torino, Italy., De Mercanti SF; Department of Clinical and Biological Sciences, University of Torino, Torino, Italy., Bardina V; Department of Clinical and Biological Sciences, University of Torino, Torino, Italy.; Laboratory of Microbiology and Virology, Amedeo di Savoia Hospital, Torino, Italy., Maglione A; Department of Clinical and Biological Sciences, University of Torino, Torino, Italy., Taverna D; Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy., Novelli F; Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy., Cocco E; Department of Medical Science and Public Health, University of Cagliari and Multiple Sclerosis Center, Cagliari, Italy., Vladic A; Department of Neurology, Clinical Hospital Sveti Duh Zagreb and Medical Faculty, University J.J Strossmayer Osijek, Prague, Croatia., Habek M; Referral Center for Autonomic Nervous System, University Hospital Center Zagreb, Zagreb, Croatia.; School of Medicine, University of Zagreb, Zagreb, Croatia., Adamec I; Referral Center for Autonomic Nervous System, University Hospital Center Zagreb, Zagreb, Croatia.; School of Medicine, University of Zagreb, Zagreb, Croatia., Annovazzi POL; Multiple Sclerosis Centre, Gallarate Hospital, ASST Valle Olona, Gallarate, Italy., Horakova D; Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czechia., Clerico M; Department of Clinical and Biological Sciences, University of Torino, Torino, Italy.

Publikováno v: Frontiers in immunology [Front Immunol] 2022 Feb 28; Vol. 13, pp. 818325. Date of Electronic Publication: 2022 Feb 28 (Print Publication: 2022).

Case Report: Covid-19 in Multiple Sclerosis Patients Treated With Ocrelizumab: A Case Series.

Autor: De Mercanti SF; S.S.D. Patologie Neurologiche Specialistiche, AOU San Luigi Gonzaga, Orbassano, Italy., Vercellino M; Department of Neurosciences and Mental Health, Multiple Sclerosis Center, AOU Città della Salute e della Scienza di Torino, Turin, Italy., Bosa C; Department of Neurosciences and Mental Health, Multiple Sclerosis Center, AOU Città della Salute e della Scienza di Torino, Turin, Italy., Alteno A; Department of Neurosciences and Mental Health, Multiple Sclerosis Center, AOU Città della Salute e della Scienza di Torino, Turin, Italy., Schillaci V; Department of Neurosciences and Mental Health, Multiple Sclerosis Center, AOU Città della Salute e della Scienza di Torino, Turin, Italy., Clerico M; S.S.D. Patologie Neurologiche Specialistiche, AOU San Luigi Gonzaga, Orbassano, Italy., Cavalla P; Department of Neurosciences and Mental Health, Multiple Sclerosis Center, AOU Città della Salute e della Scienza di Torino, Turin, Italy.

Publikováno v: Frontiers in neurology [Front Neurol] 2021 Oct 20; Vol. 12, pp. 691616. Date of Electronic Publication: 2021 Oct 20 (Print Publication: 2021).

MRI activity and extended interval of Natalizumab dosing regimen: a multicentre Italian study.

Autor: De Mercanti SF; Clinical and Biological Sciences Department, Neurology Unit, University of Torino, San Luigi Gonzaga Hospital, Orbassano, Torino, Italy. Electronic address: sdemercanti@yahoo.it., Signori A; Department of Health Sciences, Section of Biostatistics, University of Genova, Italy., Cordioli C; Multiple Sclerosis Center, Spedali Civili of Brescia, Presidio di Montichiari, Brescia, Italy., Signoriello E; Department of Medical, Surgical, Neurological, Metabolic and Aging Sciences, Second University of Naples, Italy., Lus G; Department of Medical, Surgical, Neurological, Metabolic and Aging Sciences, Second University of Naples, Italy., Bonavita S; Clinic of Neurology, AOU - University of Campania 'Luigi Vanvitelli', Napoli, Italy., Abbadessa G; Clinic of Neurology, AOU - University of Campania 'Luigi Vanvitelli', Napoli, Italy., Lavorgna L; Clinic of Neurology, AOU - University of Campania 'Luigi Vanvitelli', Napoli, Italy., Maniscalco GT; Neurological Clinic and Multiple Sclerosis Centre of 'AORN A.Cardarelli', Naples, Italy., Curti E; Neurology Unit, Department of Medicine and Surgery, University of Parma, Parma, Italy., Lorefice L; Multiple Sclerosis Center, Binaghi Hospital, Department of Medical Sciences and Public Health, University of Cagliari, Italy., Cocco E; Multiple Sclerosis Center, Binaghi Hospital, Department of Medical Sciences and Public Health, University of Cagliari, Italy., Nociti V; Multiple Sclerosis Center, Neuroscience Area, Neuroscience, Aging, Head and Neck and Orthopaedics Sciences Department, Fondazione Policlinico Universitario Gemelli, Roma, Italy., Mirabella M; Multiple Sclerosis Center, Neuroscience Area, Neuroscience, Aging, Head and Neck and Orthopaedics Sciences Department, Fondazione Policlinico Universitario Gemelli, Roma, Italy., Baroncini D; Centro Sclerosi Multipla - Presidio ospedaliero di Gallarate - ASST Valle Olona, Italy., Mataluni G; UOSD Centro di Riferimento Regionale Sclerosi Multipla - Dipartimento di Neuroscienze Policlinico Tor Vergata, Roma, Italy., Landi D; UOSD Centro di Riferimento Regionale Sclerosi Multipla - Dipartimento di Neuroscienze Policlinico Tor Vergata, Roma, Italy., Petruzzo M; Department of Neurosciences, Reproductive Sciences and Odontostomatology, Multiple Sclerosis Centre, Federico II University, Naples, Italy., Lanzillo R; Department of Neurosciences, Reproductive Sciences and Odontostomatology, Multiple Sclerosis Centre, Federico II University, Naples, Italy., Gandoglia I; Dept of Neuroscience, Rehabilititation, Ophthalmology, Genetics, Maternal and Child Health, Center of Excellence for Biomedical Research, University of Genova, Italy., Laroni A; IRCCS Ospedale Policlinico San Martino, Genova, Italy., Frangiamore R; Department of Neuroimmunology and Neuromuscular Diseases, Neurological Institute C. Besta, IRCCS Foundation, Milan, Italy., Sartori A; Neurology Unit, Azienda Sanitaria Univeristaria Integrata Clinica Neurologica, Azienda Ospedaliero-Universitaria Ospedali Riuniti di Trieste, Italy., Cavalla P; Department of Neuroscience, Città della Salute e della Scienza di Torino University Hospital, Torino, Italy., Costantini G; Department of Neuroscience, Città della Salute e della Scienza di Torino University Hospital, Torino, Italy., Capra R; Multiple Sclerosis Center, Spedali Civili of Brescia, Presidio di Montichiari, Brescia, Italy., Sormani MP; Clinical and Biological Sciences Department, Neurology Unit, University of Torino, San Luigi Gonzaga Hospital, Orbassano, Torino, Italy., Clerico M; Clinical and Biological Sciences Department, Neurology Unit, University of Torino, San Luigi Gonzaga Hospital, Orbassano, Torino, Italy.

Publikováno v: Journal of the neurological sciences [J Neurol Sci] 2021 May 15; Vol. 424, pp. 117385. Date of Electronic Publication: 2021 Mar 06.

Online Validation of a Battery of Questionnaires for the Assessment of Family Functioning and Related Factors.

Autor: Lavorgna L; Department of Advanced Medical and Surgical Sciences, University of Campania Luigi Vanvitelli, Naples, Italy., Di Tella M; Department of Psychology, University of Turin, Turin, Italy., Miele G; II Clinic of Neurology, AOU University of Campania 'Luigi Vanvitelli', Naples, Italy., De Mercanti SF; Department of Clinical and Biological Sciences, School of Medicine, University of Turin, AOU San Luigi Gonzaga, Turin, Italy., Streito LM; Department of Clinical and Biological Sciences, School of Medicine, University of Turin, AOU San Luigi Gonzaga, Turin, Italy., Perutelli V; Department of Psychology, University of Turin, Turin, Italy., Bonavita S; II Clinic of Neurology, AOU University of Campania 'Luigi Vanvitelli', Naples, Italy., Castelli L; Department of Psychology, University of Turin, Turin, Italy., Clerico M; Department of Clinical and Biological Sciences, School of Medicine, University of Turin, AOU San Luigi Gonzaga, Turin, Italy.

Publikováno v: Frontiers in psychology [Front Psychol] 2020 Apr 28; Vol. 11, pp. 771. Date of Electronic Publication: 2020 Apr 28 (Print Publication: 2020).